Latest Headlines

1. LabVantage Solutions Launches Version 8.8 Of Its Flagship LIMS Platform 12/7/2022

   LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services, including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, today announced the launch of version 8.8 of its industry-leading LabVantage LIMS platform.

2. AnX Robotica Partners With GastroGPO, A Specialty Networks Company 12/7/2022

   AnX Robotica Corporation (www.anxrobotics.com), the developer and manufacturer of the NaviCam® Magnetically Controlled Capsule Endoscopy System (MCCE), is pleased to announce a partnership with GastroGPO, a Specialty Networks Company.

3. Millstone Medical Outsourcing, An Arlington Capital Partners Portfolio Company, Acquires Ethide Laboratories 12/6/2022

   Millstone Medical Outsourcing (“Millstone”), the industry’s leading partner of choice for medical manufacturers’ post-manufacturing and aftermarket services, announces its completed acquisition of Ethide Laboratories (“Ethide Labs” or “Ethide”), on November 14, 2022.

4. Pierian Selected By PreCheck Health Services To Support Hereditary Cancer Testing For Providers And Patients 12/6/2022

   Pierian®, a global leader in advanced clinical genomics technology and services, announced a collaboration to support PreCheck Health Services, a CLIA-registered, CAP-accredited high complexity laboratory, in providing cancer-related genomic testing programs for medical practices and patients.

5. Thermo Fisher Scientific Launches TrueMark Infectious Disease Research Panels 12/6/2022

   Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the TrueMark Infectious Disease Research Panels designed to enable rapid and accurate detection and categorization for investigating microorganisms that cause respiratory, vaginal, urinary, gastrointestinal, and sexually transmitted diseases. 

6. Bluestar Genomics Initiates One Of The Largest Clinical Trials For Early Detection Of Pancreatic Cancer 12/6/2022

   Bluestar Genomics, Inc., an early cancer detection company leading the development and commercialization of next-generation liquid biopsy tests initially focused on non-invasive detection of high-mortality cancers in high-risk patient populations before symptoms appear, announced the initiation of the New Onset Diabetes Management for Earlier Detection (NODMED) trial, one of the largest clinical studies in pancreatic cancer to date.

7. COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization In The United States 12/6/2022
8. Lucira And Loch Lomond Villa Announce Clinical Study To Tackle Tripledemic With First And Only Combination COVID-19 And Flu OTC Molecular Self-Test 12/6/2022

   Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health" or "Lucira"), a medical technology company, and Loch Lomond Villa, one of New Brunswick’s largest long-term health facility operators announced today a clinical study to simultaneously test residents, medical and support staff, and visitors for COVID-19 and Influenza A/B infection with the Lucira COVID-19 & Flu Test.

9. Alcresta Therapeutics Announces Move To New Corporate Headquarters In Waltham, MA 12/5/2022

   Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel enzyme-based products, today announced that it has moved its corporate headquarters to the Stony Brook Office Park in Waltham, MA.

10. Telethon Kids Institute Researchers Discover New Form Of Antimicrobial Resistance 11/30/2022

    AMR is expected to claim 10 million lives a year by 2050, with scientists racing to understand and get ahead of the diminishing benefits of antibiotics.